Disrupted in Renal Carcinoma 2 (DIRC2) Peptid
DIRC2
Reaktivität: Säugetier
Wirt: Synthetic
BP, WB, IHC
Produktnummer ABIN936149
Kurzübersicht für Disrupted in Renal Carcinoma 2 (DIRC2) Peptid (ABIN936149)
Target
DIRC2
(Disrupted in Renal Carcinoma 2 (DIRC2))
Spezies
Säugetier
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Protein-Typ
- Synthetic
-
Sequenz
- AAESSRAHIK DRIEAVLYAE FGVVCLIFSA TLAYFPPRPP LPPSVAAASQ
-
Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of DIRC2 antibody,
Alternative Names: DIRC2 control peptide, DIRC2 antibody Blocking Peptide, Anti-DIRC2 Blocking Peptide, Disrupted In Renal Carcinoma 2 Blocking Peptide, FLJ14784 Blocking Peptide, RCC4 Blocking Peptide, DIRC2, DIRC-2, DIRC 2, DIRC-2 Blocking Peptide, DIRC 2 Blocking Peptide
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C long term.
-
-
- DIRC2 (Disrupted in Renal Carcinoma 2 (DIRC2))
-
Hintergrund
- DIRC2 is a membrane-bound protein from the major facilitator superfamily of transporters. Disruption of DIRC2 by translocation has been associated with haplo-insufficiency and renal cell carcinomas. Alternatively spliced transcript variants have been described, but their biological validity has not yet been determined.
-
Molekulargewicht
- 52 kDa
Target
-
Sie sind hier:
